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Background
Defining the quality of HIV T cell responses is a major hur-
dle in the development of T cell based vaccines. A key
determinant of viral control is the affinity of the T Cell
Receptor (TCR) for the HLA/epitope complex. We report
for the first time in HIV the development of Class I HLA
tetramers, which allow detection of CD8 with high TCR
affinity that may prove to be invaluable in assessing the
quality of T cell immunity.
Methods
HLA Class I molecules A*0201 and B*0702 were mutated
at positions D227K and T228A to nullify CD8 binding
and refolded with HIV epitopes: SLYNTVATL (A*0201),
ILKEPVHGV (A*0201) and GPGHKARVL (B*0702).
BIACORE confirmed abolition of CD8 binding and HLA
molecule conformation. Mutated HLA monomers were
termed CD8null. Peripheral blood mononuclear cells
from HLA-matched acute patients in the SPARTAC trial (n
= 30) were stained with A*0201 or B*0702 CD8 wild-type
and CD8null tetramers. Real-time Image Flow Cytometry,
directly examined the CD8null and CD8 wild-type
tetramer/TCR interaction on an individual cell level.
Results
HLA Class I A*0201 and B*0702 CD8 null monomers
had undetectable CD8 binding. Wild-type monomers had
comparable CD8 binding capacity for A*0201 and
B*0702 (KD = 5.9 × 10-4 and 6.0 × 10-4 M, respectively).
Both CD8wild-type and CD8null monomers are bound
by the anti-HLA w6/32 antibody with equal affinity (KD
= 4.2 × 10-10 M). Ex vivo imaging showed slower internal-
isation of CD8null, compared to CD8wild-typetetramers,
indicating prolonged HLA/TCR interaction. HIV patients
stained with CD8null and CD8wild-type had distinct high
affinity CD8 populations for A*0201 SLYNTVATL and
ILKEPVHGV (p < 0.05) but not for B*0702 GPGHKARVL.
Conclusion
CD8null tetramers represent a novel technology that
allow the direct ex vivo detection and characterisation of
high affinity CD8 T responses. This represents a crucial
new tool for assessing the quality of T cell responses to
vaccination.
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